Andrew Spaventa - Mar 4, 2022 Form 4 Insider Report for Singular Genomics Systems, Inc. (OMIC)

Role
Chief Executive Officer, Director
Signature
/s/ Dalen Meeter, Attorney-in-Fact
Stock symbol
OMIC
Transactions as of
Mar 4, 2022
Transactions value $
$0
Form type
4
Date filed
3/8/2022, 06:07 PM
Previous filing
Feb 11, 2022
Next filing
Mar 24, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OMIC Employee Stock Option (right to buy) Award $0 +1M $0.00 1M Mar 4, 2022 Common Stock 1M $7.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option shares vest and become exercisable in 48 equal monthly installments measured from March 4, 2022.